From: Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
KPS score | Group A(n = 27) Mean ± SD | Group B (n = 26) Mean ± SD | P value |
---|---|---|---|
T1 | 79.62 ± 8.07 | 80.38 ± 12.15 | 0.792 |
T2 | 73.70 ± 6.87 | 73.46 ± 6.89 | 0.899 |
T3 | 91.11 ± 8.00 | 93.46 ± 6.89 | 0.257 |
T4 | 71.11 ± 21.89 | 89.61 ± 13.10 | 0.001 |